Please enable JavaScript
Powered by Benchmark International Archives - Page 1752 of 2024 - Matribhumi Samachar English
Saturday, February 21 2026 | 03:38:12 PM
Home / International (page 1752)

International

CareRx Reports Results for the Fourth Quarter of 2024

Well Positioned for the Next Stage of Growth Toronto, Ontario–(Newsfile Corp. – March 5, 2025) – CareRx Corporation (TSX: CRRX) (“CareRx” or the “Company”), Canada’s leading provider of pharmacy services to seniors living and other congregate care communities, today reported its financial results for the fourth quarter ended December 31, …

Read More »

Pasofino Gold Provides Update to Its March 3, 2025 Press Release

Toronto, Ontario–(Newsfile Corp. – March 5, 2025) – Further to the press release issued by Pasofino Gold Limited (TSXV: VEIN) (OTCQB: EFRGF) (FSE: N07A) (“Pasofino” or the “Company”) on March 3, 2025, Pasofino hereby alerts shareholders that it has provided the Ontario Securities Commission (the “OSC”) with an undertaking (the …

Read More »

Boba Mint Announces Closing of Strategic Investment in Leading Blockchain/Crypto Gaming Company Werd Studios

Vancouver, British Columbia–(Newsfile Corp. – March 5, 2025) – Boba Mint Holdings Ltd. (CSE: TNJ) (“Boba” or the “Company”), is pleased to announce that it has completed its previously-announced (see press release dated January 17, 2025) arm’s length strategic investment in Werd Studios Inc. (“Werd Studios”), a fast-growing blockchain/crypto gaming …

Read More »

Atlas Lithium Strengthens Position in Critical Minerals with Rare Earths, Titanium, Graphite, and Uranium Exposure

Boca Raton, Florida–(Newsfile Corp. – March 5, 2025) – Atlas Lithium Corporation (NASDAQ: ATLX), a leading lithium exploration and development company, is pleased to highlight its current 32.2% stake in Atlas Critical Minerals Corporation. This ownership positions Atlas Lithium at the forefront of Brazil’s critical minerals sector, providing exposure to …

Read More »

Phio Pharmaceuticals Announces Completion of Enrollment in Third Safety Cohort in PH-762 Phase 1b Dose-Escalation Study

Marlborough, Massachusetts–(Newsfile Corp. – March 5, 2025) – Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company developing therapeutics that use its INTASYL® siRNA gene silencing technology designed to make the body’s immune cells more effective in killing cancer cells. Phio announced today that it has fulfilled the required …

Read More »

Hemostemix Sells Its 23rd ACP-01 Therapy Convertible Debenture

Calgary, Alberta–(Newsfile Corp. – March 5, 2025) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or “HEM”), an autologous angiogenic stem cell therapy company that has safely treated 498 patients for various forms of cardiovascular disease, including peripheral arterial disease, chronic limb threatening ischemia, non ischemic dilated cardiomyopathy, ischemic …

Read More »

Edison Issues Report on Verve Group (VER)

London, United Kingdom–(Newsfile Corp. – March 5, 2025) – Edison issues report on Verve Group (OMX: VER). Verve delivered a strong Q424, with organic net revenue growth of 24%, and resultant progress for the full year of 36% to €437m, clearly outstripping our modelled €420m. The group’s focus on ID-less …

Read More »